Stonnington Group, LLC Pacira Bio Sciences, Inc. Transaction History

Stonnington Group, LLC

$381 Million
Q1 2023

A detailed history of Stonnington Group, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Stonnington Group, LLC holds 12,019 shares of PCRX stock, worth $234,009. This represents 0.13% of its overall portfolio holdings.

Number of Shares

12,019

Previous 14,019 14.27%

Holding current value

$234,009

Previous $541,000 9.43%

% of portfolio

0.13%

Previous 0.15%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	SELL	$35.53 - $43.38 $71,060 - $86,760	-2,000 Reduced 14.27%	12,019 $490,000
Q4 2022 Jan 11, 2023	SELL	$38.19 - $57.45 $591,945 - $890,475	-15,500 Reduced 52.51%	14,019 $0
Q3 2022 Oct 20, 2022	BUY	$51.24 - $58.89 $329,063 - $378,191	6,422 Added 27.8%	29,519 $1.57 Million
Q2 2022 Jul 08, 2022	SELL	$51.49 - $81.64 $1.21 Million - $1.92 Million	-23,500 Reduced 50.43%	23,097 $1.34 Million
Q1 2022 Apr 12, 2022	SELL	$60.03 - $76.49 $16.3 Million - $20.8 Million	-272,232 Reduced 85.38%	46,597 $3.41 Million
Q4 2021 Jan 12, 2022	BUY	$47.97 - $62.21 $13.1 Million - $17 Million	273,282 Added 600.0%	318,829 $19.8 Million
Q4 2021 Jan 12, 2022	BUY	$47.97 - $62.21 $1.16 Million - $1.5 Million	24,100 Added 112.37%	45,547 $2.83 Million
Q3 2021 Oct 12, 2021	SELL	$54.64 - $61.3 $224,024 - $251,330	-4,100 Reduced 16.05%	21,447 $1.03 Million
Q2 2021 Jul 09, 2021	BUY	$59.18 - $69.99 $29,590 - $34,995	500 Added 2.0%	25,547 $1.44 Million
Q1 2021 May 21, 2021	BUY	$59.31 - $78.82 $1.49 Million - $1.97 Million	25,047 New	25,047 $1.55 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.

Account

Stonnington Group, LLC Pacira Bio Sciences, Inc. Transaction History